Regulatory Barriers to Research on Cannabis and Cannabinoids: A Proposed Path Forward.

Abstract

Cannabis and Cannabinoid ResearchVol. 4, No. 1 White PaperRegulatory Barriers to Research on Cannabis and Cannabinoids: A Proposed Path ForwardDaniele Piomelli, Robert Solomon, Donald Abrams, Agnes Balla, Igor Grant, Thomas Marcotte, and John YoderDaniele Piomelli*Address for correspondence: Daniele Piomelli, PhD, Gillespie Neuroscience Facility, Room 3101, Irvine, CA 92697-1275, E-mail Address: piomelli@uci.eduDepartment of Anatomy and Neurobiology, Center for the Study of Cannabis, University of California, Irvine, School of Medicine, Irvine, California.Search for more papers by this author, Robert SolomonEconomic Development Clinic, Center for the Study of Cannabis, University of California, Irvine, School of Law, Irvine, California.Search for more papers by this author, Donald AbramsDepartment of Medicine, Osher Center for Integrative Medicine, University of California, San Francisco, San Francisco, California.Search for more papers by this author, Agnes BallaResearch Policy Analysis and Coordination, University of California Office of the President, Oakland, California.Search for more papers by this author, Igor GrantDepartment of Psychiatry, Center for Medicinal Cannabis Research, University of California, San Diego, San Diego, California.Search for more papers by this author, Thomas MarcotteDepartment of Psychiatry, Center for Medicinal Cannabis Research, University of California, San Diego, San Diego, California.Search for more papers by this author, and John YoderDepartment of Plant Sciences, University of California, Davis, Davis, California.Search for more papers by this authorPublished Online:14 Mar 2019https://doi.org/10.1089/can.2019.0010AboutSectionsView articleView Full TextSupplemental MaterialPDF/EPUBView Supplemental Data Permissions & CitationsPermissionsDownload CitationsTrack CitationsAdd to favorites Back To Publication ShareShare onFacebookTwitterLinked InRedditEmail View articleFiguresReferencesRelatedDetailsCited byHow and why adults use cannabis during physical activity18 May 2022 | Journal of Cannabis Research, Vol. 4, No. 1Cannabis, cannabinoids, and cannabis-based medicines: future research directions for analgesia9 May 2022 | Regional Anesthesia & Pain Medicine, Vol. 47, No. 7With Medicine in Mind? Exploring the Relevance of Having Recreational Experience When Becoming a Medicinal Cannabis User20 January 2022 | Contemporary Drug Problems, Vol. 49, No. 2Between Science and Big Business: Tapping Mary Jane’s Uncharted Potential26 January 2022 | ACS Central Science, Vol. 8, No. 2Cannabis use and psychosocial functioning: evidence from prospective longitudinal studiesCurrent Opinion in Psychology, Vol. 38Medicinal Applications of Cannabinoids Extracted from Cannabis sativa (L.): A New Route in the Fight Against COVID-19?Current Pharmaceutical Design, Vol. 27, No. 13A within-person comparison of the subjective effects of higher vs. lower-potency cannabisDrug and Alcohol Dependence, Vol. 216Archives of Biochemistry and Biophysics, Vol. 681 Volume 4Issue 1Mar 2019 InformationCopyright 2019, Mary Ann Liebert, Inc., publishersTo cite this article:Daniele Piomelli, Robert Solomon, Donald Abrams, Agnes Balla, Igor Grant, Thomas Marcotte, and John Yoder.Regulatory Barriers to Research on Cannabis and Cannabinoids: A Proposed Path Forward.Cannabis and Cannabinoid Research.Mar 2019.21-32.http://doi.org/10.1089/can.2019.0010Published in Volume: 4 Issue 1: March 14, 2019KeywordsregulationcannabiscannabinoidPDF download